Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Tours
Clinical trial register · France

Clinical Trials in Tours, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Tours51 Nantes University Hospital11 University Hospital, Brest8 Novartis Pharmaceuticals7 Rennes University Hospital7
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Tours

270 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
University Hospital, Brest
Phase 2
218
Angers, La Roche-sur-Yon, La Rochelle, Nantes, Poitiers, Tours
2027-01-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
57
Chesnay, Clichy, Créteil, Paris, Tours
2026-12
Not yet open
AbbVie
Phase 3
520
Nice, Tours, Vandœuvre-lès-Nancy, Nantes, Avignon
2026-11-30
Not yet open
University Hospital, Tours
Phase 3
266
Angers, Caen, Lille, Marseille, Nantes, Strasbourg, Tours
2026-11-15
Not yet open
Hospices Civils de Lyon
Not applicable
128
Bordeaux, Limoges, Lyon, Marseille, Paris, Tours
2026-10-22
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
56
Nice, Paris, Reims, Rouen, Tours
2026-10-01
Recruiting
Poitiers University Hospital
Not applicable
460
La Roche-sur-Yon, La Rochelle, Le Mans, Poitiers, Rennes, Saintes, Tours
2026-09-16
Not yet open
University Hospital, Tours
Phase 3
164
Tours, Angers, Orléans
2026-09-16
Not yet open
Centre Hospitalier Régional d'Orléans
Not applicable
28
Angers, Nantes, Orléans, Tours
2026-09-15
Not yet open
TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study
NCT07821008Subarachnoid Hemorrhage, Aneurysmal, Brain Ischemia, Endovascular Procedure
University Hospital, Toulouse
Phase 3
274
Bordeaux, Montpellier, Nantes, Paris, Strasbourg, Toulouse, Tours
2026-09-14
Recruiting
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
MicroPort CRM
Not applicable
450
Annecy, Clermont-Ferrand, Grenoble, Montpellier, Rouen, Tours
2026-06-23
Recruiting
A Study of MZE782 in Adults With PKU
NCT07694440Phenylketonuria (PKU)
Maze Therapeutics
Phase 2
38
Tours
2026-06-23
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
132
Marseille, Montpellier, Tours
2026-06-12
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Angers, Brest, Bron, Montpellier, Nice, Paris, Rennes, Tours
2026-06-11
Recruiting
EXPLOration of Processes Involved in Dissociative Identity Disorder (DID)
NCT07663890Dissociative Identity Disorder (DID)
Lille University
Observational
60
Carvin, Chambray-lès-Tours, Lille, Tours
2026-06-04
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Saint-Etienne, Brest, Tours, Paris
2026-06-02
Not yet open
Role of the Environment in Pediatric Obesity
NCT07545174Obesity (Disorder)
University Hospital, Tours
Not applicable
80
Tours
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Amiens, Lyon, Montpellier, Nantes, Poitiers, Talence, Toulouse, Tours
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 1
360
Marseille, Pierre-Bénite, Toulouse, Tours
2026-05-13
Recruiting
University Hospital, Tours
Observational
200
Tours
2026-05-07
Not yet open
University Hospital, Tours
Observational
110
Tours
2026-05
Recruiting
University Hospital, Tours
Observational
30
Tours
2026-04-23
Recruiting
University Hospital, Tours
Observational
10,000
Angers, Lille, Toulouse, Tours
2026-04-09
Recruiting
University Hospital, Brest
Phase 3
406
Brest, Colombes, Créteil, Morlaix, Orléans, Poitiers, Rennes, Tours
2026-04-08
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Montpellier, Paris
2026-04-02
Not yet open
University Hospital, Tours
Observational
60
Limoges, Lyon, Tours
2026-04
Not yet open
University Hospital, Tours
Observational
100
Tours
2026-04
Not yet open
Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples
NCT07163507Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell)
University Hospital, Tours
Not applicable
50
Tours
2026-04
Not yet open
University Hospital, Tours
Not applicable
224
Le Mans, Orléans, Tours
2026-04
Recruiting
University Hospital, Caen
Phase 3
2,000
Tours
2026-03-24
Recruiting
MICROBIOTA AND BLADDER CANCER
NCT07080333Bladder (Urothelial, Transitional Cell) Cancer
Centre Hospitalier Universitaire de Nice
Not applicable
95
Cannes, Marseille, Menton, Nice, Nîmes, Paris, Rennes, Tours
2026-03-23
Recruiting
Amgen
Phase 3
406
Nice, Pessac, Toulouse, Tours
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Lyon, Marseille, Nice, Paris, Tours
2026-03-23
Recruiting
Centre Hospitalier de PAU
Observational
1,000
Annecy, Bordeaux, Chalon-sur-Saône, Lyon, Paris, Strasbourg, Toulouse, Tours
2026-03-19
Recruiting
University Hospital, Tours
Observational
60
Le Mans, Orléans, Tours
2026-03-19
Recruiting
Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.
NCT06748118Chronic Disease, Therapeutic Adherence, Training Group, Sensitivity, Delivery Simple, Standardized & Redundant Message to Patient
Assistance Publique - Hôpitaux de Paris
Not applicable
1,210
Angers, Antibes, Issy-les-Moulineaux, Marseille, Nantes, Paris, Toulouse, Tours
2026-03-18
Recruiting
Sanofi
Phase 2/3
526
Bordeaux, Nantes, Paris, Toulouse, Tours
2026-03-13
Recruiting
University Hospital, Lille
Not applicable
66
Lille, Tours, Amiens, Brest, Bron, Caen, Chambéry, Clermont-Ferrand
2026-03-10
Recruiting
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NCT07246265Sickle Cell Disease, Glomerular Hyperfiltration, Sickle Cell Nephropathy, Vaso-Occlusive Crises
University Hospital, Tours
Not applicable
100
Tours, Créteil, Le Mans, Nantes, Orléans, Rennes
2026-03-05
Recruiting
C4 Therapeutics, Inc.
Phase 2
100
Bayonne, Lyon, Marseille, Rouen, Toulouse, Tours, Villejuif
2026-02-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Lyon, Strasbourg, Marseille, Plérin, Brest, Toulouse, Limoges, Tours
2026-02-16
Recruiting
Study of Alloknesia in Atopic Dermatitis
NCT06923202Atopic Dermatosis, Alloknesie
University Hospital, Brest
Observational
160
Angers, Brest, La Roche-sur-Yon, Lorient, Nantes, Rennes, Tours, Vannes
2026-02-10
Recruiting
AstraZeneca
Phase 2
124
Angers, Brive-la-Gaillarde, La Roche-sur-Yon, Limoges, Strasbourg, Tours
2026-02-10
Recruiting
Neuravi Limited
Not applicable
74
Bordeaux, Toulouse, Tours
2026-02-02
Recruiting
Prilenia
Phase 3
500
Lille, Marseille, Nice, Paris, Tours
2026-02-01
Recruiting
BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus
NCT07070089Pulsatile Tinnitus, Venous Sinus Stenosis
Sonorous NV, Inc
Not applicable
90
Bordeaux, Montpellier, Paris, Tours
2026-02-01
Recruiting
University Hospital, Grenoble
Observational
1,600
Amiens, Melun, Paris, Poitiers, Reims, Tours
2026-01-15
Recruiting
AbbVie
Phase 2/3
680
Epagny Metz Tessy, Dunkirk, Lille, Montpellier, Tours, Vannes, Pessac, Poitiers
2026-01-08
Not yet open
Rennes University Hospital
Observational
2,766
Angers, Le Mans, Nantes, Poitiers, Strasbourg, Toulouse, Tours
2026-01
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
University Hospital, Angers
Not applicable
300
Angers, Rennes, Tours
2025-12-17
Not yet open
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398Organ Transplantation, Liver Dysfunction, Liver Diseases
Rennes University Hospital
Phase 2
99
Clichy, Lyon, Montpellier, Rennes, Tours, Villejuif
2025-12-15
Not yet open
University Hospital, Tours
Not applicable
15
Tours
2025-12-15
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Le Mans, Nantes, Orléans, Paris, Pointe à Pitre, Rennes, Tours
2025-12-13
Recruiting
Nantes University Hospital
Not applicable
248
Brest, Quimper, Fleury-les-Aubrais, Tours, Bouguenais, Nantes
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Lyon, Montpellier, Nantes, Nîmes, Paris, Tours
2025-12-10
Recruiting
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
NCT06892951Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection, Pneumocystis Infections
University Hospital, Tours
Phase 1/2
100
Orléans, Tours
2025-12-02
Recruiting
Centre Hospitalier le Mans
Observational
796
Angers, Le Mans, Tours
2025-12-01
Recruiting
Nantes University Hospital
Not applicable
266
Brest, Rennes, Tours, Nantes, Clermont-Ferrand, Rouen, Poitiers
2025-11-25
Active, closed
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
NCT07161037Autosomal Dominant Polycystic Kidney Disease (ADPKD)
DrugVX-407
Vertex Pharmaceuticals Incorporated
Phase 2
26
Brest, Paris, Tours
2025-11-19
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Brest, Le Kremlin-Bicêtre, Montpellier, Nantes, Paris, Rennes, Tours
2025-11-16
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 3
126
Tours, Bron, Strasbourg
2025-11-14
Recruiting
University Hospital, Angers
Not applicable
58
Angers, Brest, Le Mans, Nantes, Rennes, Tours, Vannes
2025-11-04
Active, closed
L'Oreal
Not applicable
239
Aix-en-Provence, Bordeaux, Tours, Villeurbanne
2025-11-04
Not yet open
University Hospital, Tours
Not applicable
500
Tours
2025-10-30
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
120
Tours
2025-10-20
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Besançon, Bobigny, Bordeaux, Créteil, Nice, Paris, Poitiers, Tours
2025-10-17
Recruiting
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
NCT07237009Neurocognitive Disorders, Mild, Cognitive Impairment, Mild, Depression Mild, Apathy
KompanionCare SAS
Observational
80
Angers, Limoges, Nice, Paris, Tours
2025-10-14
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Angers, Bron, Dijon, Montpellier, Paris, Toulouse, Tours
2025-10-09
Not yet open
Rennes University Hospital
Phase 4
246
Angers, Brest, Chartres, Nantes, Poitiers, Rennes, Saint-Nazaire, Tours
2025-10-01
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bron, Dijon, Lille, Montpellier, Rennes, Tours
2025-09-29
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Clermont-Ferrand, Limoges, Montpellier, Nice, Paris, Tours
2025-09-17
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Le Kremlin Bicétre Cedex, Lille, Marseille, Paris, Rennes, Toulouse, Tours, Vandœuvre-lès-Nancy
2025-09-17
Recruiting
Hôpital NOVO
Not applicable
190
Aix-en-Provence, Brest, Caen, Dijon, Nantes, Paris, Pontoise, Tours
2025-09-04
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Nantes, Paris, Rouen, Toulouse, Tours, VandoeuvrelesNancy
2025-09-04
Not yet open
PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder
NCT07121621Attention Deficit Hyperactivity Disorder (ADHD), Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2), Methylphenidate, Obesity &Amp; Overweight
University Hospital, Tours
Phase 4
30
Tours
2025-09-01
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Grenoble, Montpellier, Paris
2025-08-28
Recruiting
AbbVie
Phase 1
135
Nice, Marseille, Lille, Tours, Toulouse
2025-08-07
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 2
180
Toulouse, Lille, Paris, Villeurbanne, Bron, Strasbourg, Tours, Vandœuvre-lès-Nancy
2025-08-06
Recruiting
Bristol-Myers Squibb
Phase 3
586
Marseille, Tours, Toulouse, Lille, Rennes, Saint-Herblain, Nancy, Bron
2025-07-21
Recruiting
University Hospital, Tours
Not applicable
90
Tours
2025-07-09
Active, closed
Novartis Pharmaceuticals
Phase 2
138
Brest, Marseille, Tours
2025-07-03
Recruiting
Ventricular Arrhythmias in Acute Myocardial Infarction
NCT07517523Ventricular Arrhythmia, Acute Myocardial Infarction (AMI)
Poitiers University Hospital
Observational
500
Caen, Dijon, Grenoble, Paris, Pau, Poitiers, Saint-Etienne, Tours
2025-06-20
Active, closed
Calluna Pharma AS
Phase 2
150
Bobigny, Paris, Rennes, Toulouse, Tours
2025-06-20
Recruiting
University Hospital, Tours
Observational
150
Tours
2025-06-03
Not yet open
Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5
NCT06825234Chronic Kidney Disease Stage 5, Chronic Kidney Disease Stage 4B
Centre Hospitalier Universitaire de Besancon
Observational
390
Besançon, Tours
2025-06
Recruiting
University Hospital, Tours
Not applicable
140
Angers, Lille, Montpellier, Nantes, Orléans, Strasbourg, Tours
2025-05-16
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
50
Angers, Dijon, Lyon, Paris, Toulouse, Tours, Villejuif
2025-05-16
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Lille, Nancy, Paris, Rouen, Toulouse, Tours
2025-05-15
Recruiting
University Hospital, Tours
Not applicable
54
Brest, Nantes, Tours
2025-05-13
Recruiting
ANRS, Emerging Infectious Diseases
Phase 1/2
238
Dijon, Lyon, Paris, Saint-Priest-en-Jarez, Tours
2025-05-09
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Bordeaux, Lomme, Tours
2025-05-06
Recruiting
Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome
NCT06720818Viral Pneumonia, Acute Respiratory Distress Syndrome (ARDS)
University Hospital, Tours
Observational
150
Tours
2025-05-05
Not yet open
Chiesi SAS
Observational
165
Tours
2025-05
Active, closed
University Hospital, Tours
Observational
80
Brest, Clermont-Ferrand, Lille, Limoges, Lyon, Nice, Tours
2025-04-11
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
400
Amiens, Caen, Grenoble, Lyon, Rouen, Tours
2025-04-10
Recruiting
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002Immunology, Allergy, Genetic Diseases, Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Lille, Lyon, Montpellier, Paris, Tours
2025-04-09
Recruiting
University Hospital, Brest
Not applicable
217
Angers, Brest, Nantes, Rennes, Tours
2025-03-27
Recruiting
Bayer
Phase 1
36
Tours, Strasbourg, Limoges, Angers, La Roche-sur-Yon, Nantes, Garches
2025-03-12
Active, closed
Takeda
Phase 3
601
Caluire-et-Cuire, Toulouse, Tours, Reims, Saint-Etienne
2025-03-10
Recruiting
Hoffmann-La Roche
Phase 2
130
La Tronche, Montpellier, Pessac, Rennes, Tours
2025-03-05
Recruiting
BeOne Medicines
Phase 3
300
Montpellier, Nantes, PierreBenite, Tours
2025-03-05
Not yet open
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
NCT06869005Childhood Cancer, Nausea with Vomiting Chemotherapy-Induced
Rennes University Hospital
Observational
150
Angers, Caen, Rennes, Saint-Herblain, Tours
2025-03
Not yet open
University Hospital, Tours
Not applicable
332
Angers, Blois, Brest, Nantes, Tours
2025-03
Recruiting
Nantes University Hospital
Observational
450
Nantes, Bordeaux, Clamart, Le Plessis-Robinson, Marseille, Paris, Toulouse, Tours
2025-02-28
Recruiting
Menarini Group
Phase 2
44
Nantes, Nice, Paris, Tours
2025-02-18
Recruiting
Bronchiolitis Clearance Airways With Seaserum
NCT06177197Bronchiolitis Acute
University Hospital, Brest
Not applicable
458
Brest, Le Mans, Lille, Marseille, Morlaix, Nantes, Rennes, Tours
2025-01-10
Recruiting
Galimedix Therapeutics Inc
Phase 2
110
Bordeaux, Lyon, Marseille, Paris, Tours
2025-01-10
Recruiting
University Hospital, Tours
Phase 3
10
Tours
2025-01-08
Recruiting
University Hospital, Tours
Phase 3
102
Tours
2025-01-08
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Argenteuil, Caen, Le Mans, Mulhouse, Nice, Tours
2025-01-03
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
180
Caluire-et-Cuire, La Roche-sur-Yon, Lomme, Montpellier, Paris, Reims, Saint-Etienne, Tours
2024-12-19
Recruiting
Basilea Pharmaceutica
Phase 3
450
Amiens, Argenteuil, Marseille, Nantes, Rennes, Tours
2024-12-11
Recruiting
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
NCT06481813Lung Cancer, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Metastatic Lung Cancer
Nantes University Hospital
Not applicable
730
Angers, Nantes, Rennes, Tours
2024-12-10
Recruiting
University Hospital, Limoges
Not applicable
756
Angers, Limoges, Poitiers, Rennes, Toulouse, Tours
2024-12-09
Active, closed
Kumquat Biosciences Inc.
Phase 1
13
Tours, Marseille
2024-12-09
Recruiting
Collection of Primary Human
NCT06407102Nasal Disease
University Hospital, Tours
Not applicable
100
Tours
2024-12-06
Recruiting
University Hospital, Tours
Not applicable
100
Angers, Roscoff, Tours, Vannes
2024-11-25
Recruiting
University Hospital, Tours
Observational
150
Tours
2024-11-22
Recruiting
dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
NCT06235645Rheumatoid Arthritis, Interstitial Lung Disease, Thoracic Ultrasound, Lung Ultrasound
University Hospital, Tours
Observational
280
Tours
2024-11-18
Recruiting
University Hospital, Tours
Not applicable
60
Tours
2024-11-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Caen, Tours, Besançon, Saint-Herblain, Lille, Lyon, Paris, Villejuif
2024-10-21
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Bron, Lille, Nice, Paris, Tours
2024-10-17
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
Cahors, Caluire-et-Cuire, Échirolles, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
600
Caluire-et-Cuire, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
University Hospital, Tours
Not applicable
118
Orléans, Pessac, Toulouse, Tours
2024-10-01
Recruiting
Identification of Early Markers for ALS
NCT07213440Amyotrophic Lateral Sclerosis (ALS)
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
60
Tours
2024-09-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Nice, Tours, Toulouse
2024-09-26
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Pierre-Bénite, Dijon, Tours, Bordeaux, La Tronche, Poitiers, Caen, Nantes
2024-09-18
Recruiting
University Hospital, Limoges
Not applicable
1,000
Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2024-09-17
Active, closed
Genmab
Phase 3
379
Strasbourg, Caen, Tours, Avignon, Bayonne, Poitiers, Lille
2024-08-13
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-07-30
Active, closed
AbbVie
Phase 2
108
Marseille, Tours, Paris, Pierre-Bénite, Le Mans
2024-07-29
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Lille, Nantes, Paris, Toulouse, Tours
2024-07-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Nice, Pessac, Marseille, Toulouse, Limoges, Tours, Nantes, Pierre-Bénite
2024-07-16
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 1/2
25
Bordeaux, Créteil, Lille, Rennes, Tours, Villejuif
2024-07-10
Recruiting
Nantes University Hospital
Not applicable
1,206
Brest, Rennes, Nantes, Angers, Tours
2024-07-08
Recruiting
Rennes University Hospital
Not applicable
180
Rennes, Tours
2024-07-01
Recruiting
University Hospital, Montpellier
Not applicable
112
Angers, Montpellier, Paris, Tours
2024-05-29
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Les Paris, Dijon, Paris, Bordeaux Cedex, Garches, Nantes, Lyon, Tours
2024-05-20
Recruiting
Hearing and Structure Preservation Via ECochG
NCT06268340Hearing Loss, Sensorineural, Severe-to-profound Hearing Loss
Advanced Bionics AG
Not applicable
102
Tours
2024-05-15
Active, closed
European Myeloma Network B.V.
Phase 2
50
La Roche-sur-Yon, Montpellier, Nantes, Poitiers, Tours
2024-05-14
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Paris, Tours, Vandœuvre-lès-Nancy
2024-04-30
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Bordeaux, Pierre-Bénite, Tours, Nîmes, Angers, Paris, Saint-Priest-en-Jarez
2024-04-22
Recruiting
Attention Deficit Hyperactivity Disorder
NCT06232226Attention Deficit Hyperactivity Disorder, Behavior Hyperactive, Behavior Disorders
Nantes University Hospital
Not applicable
80
Nantes, Brest, Tours
2024-04-11
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
398
Rennes, Tours, Metz, Lyon, Montpellier, Angers, Le Kremlin-Bicêtre, Paris
2024-04-03
Not yet open
University Hospital, Tours
Phase 3
546
Angers, Blois, Chartres, Nantes, Orléans, Poitiers, Tours
2024-04
Recruiting
Italfarmaco
Phase 3
220
Saint-Quentin, Nice, Troyes, Tours, Nantes, Angers, Amiens, Paris
2024-03-26
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-03-14
Recruiting
University Hospital, Brest
Phase 3
46
Amiens, Angers, Bordeaux, Brest, Lyon, Marseille, Montpellier, Tours
2024-03-05
Recruiting
PTC Therapeutics
Phase 3
56
Lille, Paris, Tours
2024-03-04
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Bordeaux, Paris, Rouen, Toulouse, Tours
2024-02-28
Recruiting
DEprescribing: Perceptions of PAtients Living With Advanced Cancer
NCT06193083Deprescribing, Palliative Care, Oncology
Nantes University Hospital
Observational
325
La Roche-sur-Yon, Lyon, Nantes, Paris, Saint-Herblain, Saint-Nazaire, Tours
2024-02-28
Active, closed
argenx
Phase 2
103
Bordeaux, Créteil, La Tronche, Paris, Toulouse, Tours
2024-02-17
Recruiting
University Hospital, Tours
Phase 3
374
Angers, Lyon, Nice, Nîmes, Rennes, Rouen, Toulouse, Tours
2024-01-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Rennes, Tours, Limoges, Vandœuvre-lès-Nancy, Roubaix, Pierre-Bénite, Paris
2023-12-31
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Marseille, Rennes, Tours, Bordeaux, Pessac, Lille, Rouen, Nantes
2023-12-28
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Paris, Tours, Vandœuvre-lès-Nancy
2023-12-28
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Grenoble, Lyon, Nantes, Paris, Tours
2023-12-27
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Quimper, Rennes, Tours, Bordeaux, Pessac, Poitiers, Lille, Nantes
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Rennes, Tours, Nantes, Marseille, Poitiers, Angers, Paris, Strasbourg
2023-12-12
Recruiting
Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)
NCT06064825Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Angers, Bron, Montpellier, Nantes, Paris, Strasbourg, Tours
2023-12-12
Recruiting
AbbVie
Phase 3
110
Tours, Bordeaux, Toulouse, Bron, Paris
2023-12-11
Active, closed
AnaptysBio, Inc.
Phase 2
132
Nantes, Tours
2023-12-04
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Massy, Tours, La Tronche, Ars-Laquenexy, Toulouse, Saint-Étienne-de-Montluc, Caluire-et-Cuire, Marseille
2023-11-30
Recruiting
Octapharma
Phase 4
28
Nantes, Tours
2023-11-28
Active, closed
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)
NCT06093269Hemodialysis Catheter Infection, Infection, Bacterial
DrugBlood samples
University Hospital, Tours
Phase 4
32
Orléans, Tours
2023-11-20
Recruiting
Hoffmann-La Roche
Phase 1/2
200
Pierre-Bénite, Toulouse, Tours, Villejuif
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Cannes, Tours, Nîmes, Mont-de-Marsan, Nantes, Cergy-Pontoise, Grenoble, Le Puy-en-Velay
2023-11-14
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Brest, Nantes, Rennes, Tours
2023-11-09
Recruiting
University Hospital, Tours
Phase 3
244
Tours
2023-11-07
Active, closed
AstraZeneca
Phase 3
1,835
La Tronche, Mulhouse, Nice, Nîmes, Rouen, Saint-Priest-en-Jarez, Strasbourg, Tours
2023-11-07
Recruiting
United Therapeutics
Phase 3
698
Bobigny, Bron, Caen, Marseille, Rouen, Tours
2023-10-30
Recruiting
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NCT05792007Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children
University Hospital, Tours
Not applicable
40
Tours
2023-10-26
Active, closed
Bristol-Myers Squibb
Phase 3
402
Nice, Pessac, Tours, La Tronche, Vandœuvre-lès-Nancy, Angers, Villejuif, Paris
2023-10-24
Active, closed
University Hospital, Caen
Not applicable
64,000
Tours
2023-09-14
Recruiting
Biotest
Phase 3
590
Nice, Reims, Strasbourg, Colombes, Limoges, Rennes, Tours, Grenoble
2023-09-09
Not yet open
Direction Centrale du Service de Santé des Armées
Observational
120
Clamart, Tours
2023-09
Recruiting
University Hospital, Tours
Not applicable
30
Château-Renault, Tours
2023-08-03
Recruiting
University Hospital, Tours
Not applicable
78
Tours
2023-07-27
Recruiting
University Hospital, Tours
Observational
50
Tours
2023-07-21
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Nice, Tours, Reims, Rouen, Toulouse
2023-07-11
Recruiting
POS-ARI-ER Observational Study of Acute Respiratory Infections
NCT05814237Acute Respiratory Infection, Acute Respiratory Tract Infection
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
11,750
Grenoble, Limoges, Lyon, Tours
2023-06-20
Recruiting
University Hospital, Angers
Observational
120
Angers, Brest, Nantes, Poitiers, Rennes, Tours
2023-05-17
Active, closed
University Hospital, Tours
Not applicable
118
Angers, Orléans, Toulouse, Tours
2023-05-03
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Montpellier, Paris, Toulouse, Tours
2023-04-21
Recruiting
Modelling of Pharyngeal Laryngeal Effectiveness
NCT06014710Swallowing Disorders
University Hospital, Toulouse
Not applicable
520
Bordeaux, Rouen, Toulouse, Tours
2023-04-14
Recruiting
Institut Curie
Not applicable
50
Tours, Avignon, Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier
2023-04-08
Recruiting
Centre Hospitalier Intercommunal Creteil
Not applicable
180
Brest, Corbeil-Essonnes, Créteil, Lille, Tours
2023-04-01
Recruiting
University Hospital, Brest
Not applicable
550
Amiens, Brest, Caen, Créteil, Nantes, Nice, Paris, Tours
2023-03-28
Recruiting
Eli Lilly and Company
Phase 3
595
Brest, Marseille, Nantes, Nice, Paris, Tours
2023-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
377
Quimper, Tours, Paris
2023-02-14
Recruiting
Medtronic Cardiovascular
Not applicable
400
Toulouse, Bordeaux, Créteil, Marseille, Nantes, Rennes, Saint-Denis, Tours
2023-02-07
Active, closed
Bristol-Myers Squibb
Phase 3
516
Strasbourg, Nantes, Le Kremlin-Bicêtre, Tours
2023-01-12
Recruiting
University Hospital, Tours
Not applicable
460
Tours
2023-01-03
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Pessac, Tours, Angers, Lille, Villejuif, Paris
2022-12-14
Active, closed
University Hospital, Tours
Not applicable
35
Tours
2022-12-05
Active, closed
Staging System in Amyotrophic Lateral Sclerosis
NCT04858555Amyotrophic Lateral Sclerosis
University Hospital, Limoges
Observational
50
Limoges, Tours
2022-12-02
Recruiting
University Hospital, Tours
Observational
225
Tours
2022-11-22
Active, closed
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324Amyotrophic Lateral Sclerosis
Corcept Therapeutics
Phase 2
279
Bron, Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2022-11-15
Recruiting
Pfizer
Phase 3
1,060
Nice, Toulouse, Poitiers, Nantes, Paris, Tours, Villejuif
2022-11-10
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Marseille, Rennes, Toulouse, Tours
2022-10-04
Active, closed
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
NCT05563883Atrial Fibrillation, Cancer, Thromboembolism, Bleeding
University Hospital, Caen
Observational
5,000,000
Tours
2022-09-22
Active, closed
AstraZeneca
Phase 3
607
Montpellier, Tours
2022-09-12
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Marseille, Caen, Toulouse, Tours, Rouen, Amiens, Bobigny, Bron
2022-09-06
Active, closed
Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT05471843Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma
DrugSonrotoclax
BeOne Medicines
Phase 1/2
125
Le Mans, Nantes, Paris, PierreBenite, Tours
2022-09-05
Recruiting
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259Ventilator Associated Pneumonia
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
20,000
Chalon-sur-Saône, Dijon, Le Mans, Lille, Limoges, Tours
2022-08-03
Recruiting
University Hospital, Tours
Not applicable
338
Blois, Brest, Chambray-lès-Tours, Châteauroux, Le Mans, Orléans, Saint-Benoît-la-Forêt, Tours
2022-06-23
Active, closed
Sanofi
Phase 3
531
Nantes, Paris, Poitiers, Saint-Priest-en-Jarez, Toulouse, Tours
2022-06-23
Active, closed
ModernaTX, Inc.
Phase 1/2
15
Clamart, Tours
2022-06-01
Recruiting
Rennes University Hospital
Not applicable
130
Rennes, Besançon, Le Mans, Tours
2022-05-20
Recruiting
University Hospital, Tours
Observational
600
Angers, Poitiers, Tours
2022-05-01
Recruiting
Cognitive Disorders and Brain Pulse
NCT05129150Neurocognitive Disorders
University Hospital, Tours
Observational
300
Tours
2022-03-31
Active, closed
Pfizer
Phase 3
854
Toulouse, Paris, Villejuif, Poitiers, Lille, Pierre-Bénite, Tours
2022-03-25
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
43
Boulogne-Billancourt, Nice, Tourcoing, Tours
2022-03-07
Recruiting
University Hospital, Tours
Not applicable
50
Tours
2022-03-03
Active, closed
Amyloidosis TTR Flow Reserve Evaluation
NCT05103943Amyloid Cardiomyopathy
Centre Hospitalier Régional d'Orléans
Not applicable
50
Angers, Caen, Orléans, Tours
2022-02-24
Recruiting
University Hospital, Tours
Observational
500
Tours
2021-12-08
Recruiting
University of Melbourne
Phase 2/3
688
Tours
2021-11-29
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
70
Besançon, La Tronche, Nantes, Paris, Poitiers, Toulouse, Tours
2021-10-07
Recruiting
Poitiers University Hospital
Phase 4
160
Angers, Bordeaux, Limoges, Nantes, Périgueux, Poitiers, Tours
2021-09-07
Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases
Balt Extrusion
Observational
10,000
Angers, Bordeaux, La Tronche, Lille, Paris, Tours
2021-07-12
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Clichy, Créteil, Lyon, Montpellier, Paris, Rennes, Strasbourg, Tours
2021-07-08
Active, closed
Sanofi
Observational
16
Tours
2021-06-10
Active, closed
Novartis Pharmaceuticals
Phase 2
236
Bordeaux, Dijon, Paris, Tours
2021-04-19
Active, closed
Geron Corporation
Phase 3
327
Pierre-Bénite, Tours, Paris, Nantes, Nice, Le Mans, Brest
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Amiens, Le Mans, Nice, Nîmes, Pierre-Bénite, Rennes, Saint-Priest-en-Jarez, Tours
2021-04-09
Active, closed
Economic Evaluation of Prostatic Urethral Lift
NCT04726748Benign Prostatic Hyperplasia
University Hospital, Bordeaux
Observational
1,360
Lille, Montpellier, Paris, Pierre-Bénite, Talence, Tours
2021-04-08
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bordeaux, Clermont-Ferrand, Pierre-Bénite, Brest, Nîmes, Mulhouse, Lille, Tours
2021-03-11
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Grenoble, Bobigny, Pierre-Bénite, La Roche-sur-Yon, Nîmes, Politiers, Rouen, Tours
2021-03-09
Recruiting
Hospices Civils de Lyon
Not applicable
92
Besançon, Bron, Caen, La Tronche, Montpellier, Rouen, Tours, Vandœuvre-lès-Nancy
2021-02-24
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Nantes, Rouen, Tours
2021-02-23
Active, closed
BioNTech SE
Phase 2/3
358
Bordeaux, Caen, Dijon, Marseille, Paris, Tours, Villejuif
2021-01-07
Recruiting
University Hospital, Limoges
Not applicable
430
Limoges, Poitiers, Rennes, Tours
2020-12-21
Active, closed
GlaxoSmithKline
Phase 2/3
758
Créteil, Grenoble, Marseille, Nice, Quimper, Rennes, Tours
2020-12-08
Active, closed
Bayer
Phase 3
774
Clermont-Ferrand, Pierre-Bénite, Dijon, Brest, Rennes, Tours, Reims, Bordeaux
2020-10-20
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Lille, Lyon, Nantes, Poitiers, Toulouse, Tours
2020-09-17
Active, closed
University Hospital, Tours
Not applicable
100
Angers, Rennes, Saint-Herblain, Tours
2020-09-01
Active, closed
Incyte Corporation
Phase 2
112
Brest, Nice, Paris, Toulouse, Tours
2020-08-03
Recruiting
University of Calgary
Phase 3
440
Tours
2020-07-14
Recruiting
Nantes University Hospital
Phase 3
110
Angers, Brest, Limoges, Nantes, Rennes, Tours
2020-06-19
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Bordeaux, Lyon, Nice, Pierre-Bénite, Strasbourg, Tours, Villejuif-Cedex-France
2020-03-30
Active, closed
BeOne Medicines
Phase 3
955
Bordeaux, La Roche-sur-Yon, Le Mans, Paris, Tours
2020-01-16
Recruiting
Comprehensive Aneurysm Management Trial
NCT04155606Saccular Aneurysm, Intracranial Aneurysm, Unruptured Cerebral Aneurysm
Centre hospitalier de l'Université de Montréal (CHUM)
Not applicable
2,000
Tours
2020-01-15
Active, closed
Rennes University Hospital
Not applicable
37
Angers, Brest, Nantes, Poitiers, Rennes, Saint-Avé, St-Malo, Tours
2019-11-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Besançon, Caen, Dijon, Lyon, Tours, Le Mans, Brest, Grenoble
2019-10-02
Active, closed
Celgene
Phase 1/2
424
Lille, Marseille, Nantes, Toulouse, Tours
2019-09-30
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Tours, Montpellier, Clermont-Ferrand, Rennes, Bordeaux, Caen, Dijon, La Tronche
2019-09-27
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808Unruptured Intracranial Aneurysm
Nantes University Hospital
Observational
1,000
Marseille, Brest, Bordeaux, Toulouse, Limoges, Rennes, Tours, Nantes
2019-08-19
Active, closed
OncoVerity, Inc.
Phase 2
103
Angers, Grenoble, Marseille, Pessac, Pierre-Bénite, Toulouse, Tours
2019-07-29
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Marseille, Nantes, Rennes, Tours
2019-04-26
Recruiting
Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions
NCT05685069Silent Stroke, Silent Cerebral Infarct, Covert Brain Infarct, Covert Brain Infarction
Insel Gruppe AG, University Hospital Bern
Observational
230
Tours
2019-03-01
Active, closed
Poitiers University Hospital
Not applicable
143
Amiens, Lyon, Poitiers, Tours
2019-02-07
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Créteil, Montpellier, Paris, Pierre-Bénite, Rouen, Tours
2018-06-26
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Clermont-Ferrand, Lille, Montpellier, Pessac, Reims, Toulouse, Tours, Vandœuvre-lès-Nancy
2018-04-17
Active, closed
AbbVie
Phase 2
156
Limoges, Tours, Nantes, Villejuif, Poitiers, Paris
2018-04-02
Recruiting
University Hospital, Brest
Observational
2,640
Brest, Clermont-Ferrand, Morlaix, Paris, Rennes, Saint-Etienne, Tours
2017-10-24
Active, closed
Genzyme, a Sanofi Company
Phase 2
22
Nantes, Paris, Tours
2017-10-12
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Pessac, Tours, Nantes, Pierre-Bénite, Le Mans, Brest, Caen, Grenoble
2017-06-26
Recruiting
University Hospital, Tours
Not applicable
450
Tours
2017-06-14
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Lyon, Tours
2017-05-16
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Nîmes, Lille, Marseille, Saint-Priest-en-Jarez, Suresnes, Tours, Villejuif
2017-03-24
Active, closed
Geron Corporation
Phase 2/3
289
Nice, Tours, Limoges, La Tronche, Vandœuvre-lès-Nancy, Le Mans, Poitiers, Angers
2016-01-12
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Villejuif, Pierre-Bénite, Bordeaux, Nice, Rouen, Toulouse, Tours
2015-07-14
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
2015-05-01
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Grenoble, Paris, Tours, Vandœuvre-lès-Nancy
2014-06
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Créteil, Mulhouse, Paris, Pessac, Pierre-Bénite, Tours
2013-09-09
Recruiting
Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)
NCT02426255Severe Trauma (With or Without Traumatic Brain Injury)
Nantes University Hospital
Observational
5,000
Angers, Nantes, Poitiers, Rennes, Tours
2013-03-29
Recruiting
Nantes University Hospital
Observational
5,000
Angers, Brest, Nantes, Poitiers, Rennes, Tours
2013-02
Rows per page Showing 1–270 of 270
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-france/city/tours

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 270 of those studies with a site in Tours.

How many clinical trials are recruiting in Tours?

159 of the 270 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 26 have not yet opened recruitment, 82 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tours), 270 studies
PhaseStudiesRecruitingShare
Phase 3784128.9%
Not applicable705225.9%
Observational513518.9%
Phase 2381614.1%
Phase 1/21043.7%
Phase 2/31043.7%
Phase 4742.6%
Phase 1632.2%

Most active sponsors

Lead sponsors with the most studies (Tours)
Lead sponsorStudiesRecruiting
University Hospital, Tours5132
Nantes University Hospital1111
University Hospital, Brest87
AbbVie73
Janssen Research & Development, LLC72
Novartis Pharmaceuticals72
Rennes University Hospital72
University Hospital, Angers66
AstraZeneca53
Bristol-Myers Squibb51
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.